UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 629

Sortiert nach

Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis

Journal of the European Academy of Dermatology and Venereology, 2016-11, Vol.30 (11), p.1942-1950

2016

Volltextzugriff (PDF)

Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies

Journal of the European Academy of Dermatology and Venereology, 2014-11, Vol.28 (11), p.1424-1430

2014

Volltextzugriff (PDF)

Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Dermatology and therapy, 2024-06, Vol.14 (6), p.1479-1493

2024

Volltextzugriff (PDF)

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

British journal of dermatology (1951), 2013-03, Vol.168 (3), p.609-616

2013

Volltextzugriff (PDF)

Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis

British journal of dermatology (1951), 2012-06, Vol.166 (6), p.1237-1244

2012

Volltextzugriff (PDF)

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Dermatology and therapy, 2024-06, Vol.14 (6), p.1495-1496

2024

Volltextzugriff (PDF)

Updated Review on Treatment of Atopic Dermatitis

Journal of investigational allergology & clinical immunology, 2023-01, Vol.33 (3), p.158-167

2023

Volltextzugriff (PDF)

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab

British journal of dermatology (1951), 2021-10, Vol.185 (4), p.865-867

2021

Volltextzugriff (PDF)

Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry

Journal of the European Academy of Dermatology and Venereology, 2013-11, Vol.27 (11), p.1366-1374

2013

Volltextzugriff (PDF)

The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis

Journal of the European Academy of Dermatology and Venereology, 2020-08, Vol.34 (8), p.1695-1706

2020

Volltextzugriff (PDF)

Phototoxic reaction to a combined oral contraceptive (levonorgestrel/ethinylestradiol)

Photochemical & photobiological sciences, 2017-09, Vol.16 (9), p.1381-1383

2017

Volltextzugriff (PDF)

Redefining the therapeutic objective in psoriatic patients candidates for biological therapy

The Journal of dermatological treatment, 2018-06, Vol.29 (4), p.334-346

2018

Volltextzugriff (PDF)

Usefulness and correlation with clinical response of serum ustekinumab levels measured at 6 weeks versus 12 weeks

The Journal of dermatological treatment, 2019-01, Vol.30 (1), p.35-39

2019

Volltextzugriff (PDF)

Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis

The Journal of infection, 2014-12, Vol.69 (6), p.600-606

2014

Volltextzugriff (PDF)

Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.797-799

2017

Volltextzugriff (PDF)

Correlation between trough serum levels of adalimumab and absolute PASI score in a series of patients with psoriasis

The Journal of dermatological treatment, 2018-02, Vol.29 (2), p.140-144

2018

Volltextzugriff (PDF)

Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians

The Journal of dermatological treatment, 2017-04, Vol.28 (3), p.188-199

2017

Volltextzugriff (PDF)

[Translated article] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives

Actas dermo-sifiliográficas, 2023-09, Vol.114 (8), p.T680-T707

2023

Volltextzugriff (PDF)

Position statement for the management of comorbidities in psoriasis

Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.2058-2073

2018

Volltextzugriff (PDF)

Innovation in Atopic Dermatitis: From Pathogenesis to Treatment

Actas dermo-sifiliográficas (English ed.), 2020-04, Vol.111 (3), p.205-221

2020

Volltextzugriff (PDF)

Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives

Actas dermo-sifiliográficas (English ed.), 2023-09, Vol.114 (8), p.680-707

2023

Volltextzugriff (PDF)

Initial results of ixekizumab efficacy and safety in real‐world plaque psoriasis patients: a multicentre retrospective study

Journal of the European Academy of Dermatology and Venereology, 2019-03, Vol.33 (3), p.553-559

2019

Volltextzugriff (PDF)

Prevalence of psoriasis in Spain in the age of biologics

Actas dermo-sifiliográficas (English ed.), 2014-06, Vol.105 (5), p.504-509

2014

Volltextzugriff (PDF)

[Translated article] Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Virus (VPH) Vaccination in a Kidney Transplant Recipient

Actas dermo-sifiliográficas, 2024-01, Vol.115 (1), p.T110-T112

2024

Volltextzugriff (PDF)

[Translated article] Moderate to Severe Psoriasis in Older Adults: Recommendations on Management From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV)

Actas dermo-sifiliográficas, 2023-10, Vol.114 (9), p.T802-T811

2023

Volltextzugriff (PDF)

1 – 25 von 629

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(579)
Mit Volltextzugriff
(527)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(338)
Life Sciences & Biomedicine
(305)
Humans
(241)
Dermatology
(191)
Male
(120)
Female
(113)
Biological And Medical Sciences
(89)
Adult
(83)
Psoriasis
(80)
Middle Aged
(77)
Psoriasis - Drug Therapy
(73)
Animals
(64)
Biochemistry & Molecular Biology
(60)
Fundamental And Applied Biological Sciences. Psychology
(54)
Aged
(50)
Medical Sciences
(39)
Child
(37)
Microscopy, Electron
(37)
Internal Medicine
(34)
Adolescent
(32)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis

Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies

Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Updated Review on Treatment of Atopic Dermatitis

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab

Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry

The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis

Phototoxic reaction to a combined oral contraceptive (levonorgestrel/ethinylestradiol)

Redefining the therapeutic objective in psoriatic patients candidates for biological therapy

Usefulness and correlation with clinical response of serum ustekinumab levels measured at 6 weeks versus 12 weeks

Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis

Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort

Correlation between trough serum levels of adalimumab and absolute PASI score in a series of patients with psoriasis

Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians

[Translated article] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives

Position statement for the management of comorbidities in psoriasis

Innovation in Atopic Dermatitis: From Pathogenesis to Treatment

Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives

Initial results of ixekizumab efficacy and safety in real‐world plaque psoriasis patients: a multicentre retrospective study

Prevalence of psoriasis in Spain in the age of biologics

[Translated article] Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Virus (VPH) Vaccination in a Kidney Transplant Recipient

[Translated article] Moderate to Severe Psoriasis in Older Adults: Recommendations on Management From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV)

Suchergebnisse filtern